What is the current price / NAV of ITI Pharma & Healthcare Fund(IDCW)?
The current NAV of ITI Pharma & Healthcare Fund(IDCW) is ₹17.60, as of 13th November 2025.What are the returns of ITI Pharma & Healthcare Fund(IDCW)?
The ITI Pharma & Healthcare Fund(IDCW) was launched on 8th November 2021. This mutual fund's past returns are as follows:- 1 Year Returns: 0.89%
- 3 Year Returns: 21.28%
What are the top 5 sectoral holdings of ITI Pharma & Healthcare Fund(IDCW)?
The top sectors ITI Pharma & Healthcare Fund(IDCW) has invested in are as follows:- Pharmaceuticals | 69.11%
- Labs & Life Sciences Services | 22.62%
- Others | 2.18%
- Fertilizers & Agro Chemicals | 2.07%
- Insurance | 1.25%
What are the top 5 holdings of ITI Pharma & Healthcare Fund(IDCW)?
The top 5 holdings for ITI Pharma & Healthcare Fund(IDCW) are as follows:- Sun Pharmaceutical Industries Ltd | 10.96%
- Divi's Laboratories Ltd | 8.97%
- Apollo Hospitals Enterprise Ltd | 6.35%
- Max Healthcare Institute Ltd | 5.71%
- Torrent Pharmaceuticals Ltd | 4.51%
What is the asset allocation of ITI Pharma & Healthcare Fund(IDCW)?
The asset allocation for ITI Pharma & Healthcare Fund(IDCW) is as follows:- Equity | 98.30%
- Cash & Equivalents | 1.70%
What is the AUM of ITI Pharma & Healthcare Fund(IDCW)?
The AUM (i.e. assets under management) of ITI Pharma & Healthcare Fund(IDCW) is ₹232.83 Cr as of 13th November 2025.What is the expense ratio of ITI Pharma & Healthcare Fund(IDCW)?
The expense ratio of ITI Pharma & Healthcare Fund(IDCW) Plan is 0.47 as of 13th November 2025.What is the alpha ratio of ITI Pharma & Healthcare Fund(IDCW)?
The alpha ratio for the ITI Pharma & Healthcare Fund(IDCW) is 1.16
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of ITI Pharma & Healthcare Fund(IDCW)?
The volatility or standard deviation for the ITI Pharma & Healthcare Fund(IDCW) is 15.97
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of ITI Pharma & Healthcare Fund(IDCW)?
The Sharpe ratio for the ITI Pharma & Healthcare Fund(IDCW) is -0.09
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of ITI Pharma & Healthcare Fund(IDCW)?
The Sortino Ratio for the ITI Pharma & Healthcare Fund(IDCW) is -0.01
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of ITI Pharma & Healthcare Fund(IDCW)?
The PE ratio of ITI Pharma & Healthcare Fund(IDCW) is 47.69, while category PE ratio is 42.75.


Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%